COVID-19 Vaccination: What Challenges Are We Going to Face

COVID-19 Vaccination: What Challenges Are We Going to Face

Authors

  • Sara Zibadi Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; USERN Office, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Net-work of Interdisciplinarity in Neonates and Infants (NINI), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  • Noosha Samieefar Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; USERN Office, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Net-work of Interdisciplinarity in Neonates and Infants (NINI), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  • Fatemeh Sodeifian Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; USERN Office, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Net-work of Interdisciplinarity in Neonates and Infants (NINI), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  • Narjes Mosavari USERN Office, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Net-work of Interdisciplinarity in Neonates and Infants (NINI), Universal Scientific Education and Research Network (USERN), Tehran, Iran; Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Nima Rezaei Net-work of Interdisciplinarity in Neonates and Infants (NINI), Universal Scientific Education and Research Network (USERN), Tehran, Iran; Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
DOI: https://doi.org/10.23750/abm.v92i4.11759

Keywords:

COVID-19, SARS-CoV-2, Vaccine, Vaccination

Abstract

NA

References

Samieefar, N., et al., Country Quarantine During COVID-19: Critical or Not? Disaster Med Public Health Prep, 2020: p. 1-2.

Rawat, K., P. Kumari, and L. Saha, COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies. European journal of pharmacology, 2020: p. 173751.

WHO. COVID-19 Vaccines. [cited 2021 May 6]; . Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines.

WHO. Coronavirus disease (COVID-19): Vaccines. [cited 2021 May 6]. Available from: https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines.

WHO. Draft landscape tracker of COVID-19 candidate vaccines. [cited 2021 May 6]. Available from: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.

CDC. Different COVID-19 Vaccines. [cited 2021 May 6]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines.html.

CDC. Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in

the United States. [cited 2021 May 6]. Available from: https://www.cdc.gov/vaccines/covid19/info-by-product/clinical-considerations.html.

CDC. COVID-19 Vaccinations in United States. [cited 2021 May 6]. Available from: https://covid.cdc.gov/covid-data-tracker/#vaccinations.

So, A.D. and J. Woo, Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. bmj, 2020. 371.

Adhanom Ghebreyesus, T.J. [cited 2021 May 6]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-148th-session-of-the-executive-board.

Calina, D., et al., Towards effective COVID‑19 vaccines: Updates, perspectives and challenges. International journal of molecular medicine, 2020. 46(1): p. 3-16.

de Gomensoro, E., G. Del Giudice, and T.M. Doherty, Challenges in adult vaccination. Annals of medicine, 2018. 50(3): p. 181-192.

Chung, J.Y., M.N. Thone, and Y.J. Kwon, COVID-19 vaccines: The status and perspectives in delivery points of view. Advanced drug delivery reviews, 2020.

Badgujar, K.C., V.C. Badgujar, and S.B. Badgujar, Vaccine development against coronavirus (2003 to present): An overview, recent advances, current scenario, opportunities and challenges. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020. 14(5): p. 1361-1376.

Downloads

Published

02-09-2021

Issue

Vol. 92 No. 4 (2021)

Section

CORRESPONDENCE - SPECIAL COVID19

License

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. 
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

How to Cite

1.
Zibadi S, Samieefar N, Sodeifian F, Mosavari N, Rezaei N. COVID-19 Vaccination: What Challenges Are We Going to Face. Acta Biomed. 2021;92(4):e2021379. doi:10.23750/abm.v92i4.11759
Crossref
Scopus
Google Scholar
Europe PMC